RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 139, Issue 2, 2002, Pages 104-108

  Lee, Dong Soon ^a   Lee, Yun Song ^b   Kim, Young Ree ^a   Han, Kyu Sup ^a   Park, Kyoung Un ^a   She, Cha Ja ^a   Kim, Eu Chong ^a   Park, Sun Yang ^a   Cho, Han Ik ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MOLECULAR PROBE; ONCOGENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

BLOOD CELLS; BONE MARROW CELLS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, PROMYELOCYTIC, ACUTE; NEOPLASM PROTEINS; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; RECEPTORS, RETINOIC ACID; SENSITIVITY AND SPECIFICITY; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0036959872     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00619-2     Document Type: Article

References (12)

1. Fenaux P., Chomienne C., Degos L. Acute promyelocytic leukemia. Biology and treatment. Semin Oncol. 24:1997;92-102.
2. Huang M.E., Yc Y.C., Chen S.R., Lu M.X., Zhoa L., Gu L.J., Chai J.R., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1988;567-572.
3. Castaigne S., Chomienne C., Daniel M.T., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 76:1990;1704-1709.
4. Warrell R.P. Jr., Frankel S.R., Miller W.H. Jr., Scheinberg D.A., Itri L.M., Hittelman W.N., Vyas R., Andreef M., Tafuri A., Jakubowski A. Differentiation therapy for acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N Engl J Med. 324:1991;1385-1393.
5. Brunning R.D., McKenna R.W. Acute leukemias. Atlas of tumor pathology. Tumors of the bone marrow. 1994;19-142 Armed Forces Institute of Pathology, Washington, DC.
6. Diverio D., Rossi V., Avvisati G., De Santis S., Pistilli A., Pane F., Saglio G., Martinelli G., Petti M.C., Santoro A., Pelicci P.G., Mandelli F., Biondi A., Lo Coco F.L. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARA-alpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial. Blood. 1;92:1998;784-789.
7. Diverio D., Pandolfi P.P., Rossi V., Biondi A., Pelicci P.G., Lo Coco F. Monitoring of treatment outcome in acute promyelocytic leukemia by RT-PCR. Leukemia. 8:1994;S63-S65.
8. Martinelli G., Ottaviani E., Testoni N., Visani G., Diverio D., D'Elia G., Mandelli F., Tura S. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy. Haematologica. 83:1998;985-988.
9. Lo Coco F., Diverio D., Avvisati G., Mandelli F. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia. Haematologica. 84:1999;72-74.
10. Tobal K., Saunders M.J., Grey M.R., Yin J.A. Persistence of RAR alpha-PML fusion mRNA detected by reverse transcriptase polymerase chain reaction in patients in long-term remission of acute promyelocytic leukaemia. Br J Haematol. 90:1995;615-618.
11. Wang Y.L., Bagg A., Pear W., Nowell P.C., Hess J.L. Chronic myelogenous leukemia. laboratory diagnosis and monitoring Genes Chromosomes Cancer. 32:2001;97-111.
12. Borrow J. Diagnosis of acute promyelocytic leukemia by RT-PCR. detection of PML-RARA and RARA fusion transcript Br J Haematol. 82:1992;529-540.